US FDA Approved Two COVID-19 Boosters Targeted at Omicron Variants
The US Food and Drug Administration (FDA) authorized the updated COVID-19 booster vaccine shots from Pfizer, BioNTech and Moderns that mainly target the dominant BA.4 and BA.5 Omicron subvariants, as the government of the United States prepares for a vaccination campaign that can start in some days. Both COVID-19 vaccines also include the original version […]
Continue Reading